HMS LINCS ID,Name,Alternative Names,LINCS ID,Alternative ID,Parent Cell Line,Parent Cell Line HMS LINCS ID,Reference Source,Organism,Organ,Tissue,Cell Type,Details of Cell Type,Donor Sex,Donor Age,Donor Ethnicity,Donor Health Status,Disease,Details of Disease,Production Details,Genetic Modification(s),Known Mutations,Citation Information for Mutations,Verification Reference Profile,Growth Properties,Recommended Culture Conditions,Relevant Citations,Usage Note,Date Publicly Available,Most Recent Update
50001,5637,,LCL-1702,"<a href = ""http://purl.obolibrary.org/obo/CLO_0001421""  target=""blank"">CLO_0001421</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-9"" target=""blank"">ATCC HTB-9</a>",Homo sapiens,urinary bladder,,epithelial,,male,,,,"DOID:4007, bladder carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=687452""  target=""blank"">COSS687452</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X,Y 
CSF1PO: 11 
D13S317: 11 
D16S539: 9 
D5S818: 11,12 
D7S820: 10,11 
THO1: 7,9 
TPOX: 8,9 
vWA: 16,18",adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%. Protocol: Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:4 to 1:8 is recommended",,,2012-04-25,2016-04-04
50002,647-V,,LCL-1708,"<a href = ""http://purl.obolibrary.org/obo/CLO_0001450""  target=""blank"">CLO_0001450</a>",,,"<a href = ""https://www.dsmz.de/catalogues/details/culture/ACC-414.html?tx_dsmzresources_pi5%5BreturnPid%5D=192"" target=""blank"">Leibniz Institute DSMZ ACC 414</a>",Homo sapiens,urinary bladder,,epithelial-like,,male,,,,"DOID:4007, bladder carcinoma; DOID:4006, bladder transitional cell carcinoma",transitional cell carcinoma; urothelial bladder carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=906797""  target=""blank"">COSS906797</a>",,adherent,From MGH/CMT as specified by cell provider: 85% Dulbecco's MEM + 15% FBS + 2 mM L-glutamine split confluent culture 1:5 to 1:6 every 3-4 days using trypsin/EDTA; seed out at ca. 2 x 106 cells/80 cm 2 in 10 ml medium at 37C with 5-10% CO2 cell harvest of ca. 10-15 x 106 cells/175 cm 2,,,2012-04-25,2016-04-04
50003,A375.S2,,LCL-1231,"<a href = ""http://purl.obolibrary.org/obo/CLO_0001583""  target=""blank"">CLO_0001583</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1872"" target=""blank"">ATCC CRL-1872</a>",Homo sapiens,skin,,epithelial,,female,,,,"DOID:1909, malignant melanoma",,,none,,,"DNA Profile (STR, source: ATCC):
Amelogenin: X 
CSF1PO: 11,12 
D13S317: 11,14 
D16S539: 9 
D5S818: 12 
D7S820: 9 
THO1: 8 
TPOX: 8,10 
vWA: 16,17",adherent,"From MGH/CMT as specified by cell provider: Minimum essential medium (Eagle) with 2 mM L-glutamine and Earle's BSS adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino acids, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Subculturing: Remove medium, rinse with fresh 0.25% trypsin, 0.03% EDTA solution and let the culture sit at room temperature (or 37C) until cells detach (about 10 minutes). Add fresh medium, aspirate and dispense into new flasks.
Subcultivation ratio: A subcultivation ratio of 1:3 to 1:8 is recommended",,,2012-04-25,2016-07-12
50004,AGS,,LCL-1893,"<a href = ""http://purl.obolibrary.org/obo/CLO_0001686""  target=""blank"">CLO_0001686</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1739"" target=""blank"">ATCC CRL-1739</a>",Homo sapiens,stomach,,epithelial,,female,,,,"DOID:5517, stomach carcinoma; DOID:3717, gastric adenocarcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=906790""  target=""blank"">COSS906790</a>",,adherent,"From MGH/CMT as specified by cell provider: Ham's F12K medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 90%; fetal bovine serum, 10%",,,2012-04-25,2016-04-04
50005,BPH-1,,LCL-2095,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002022""  target=""blank"">CLO_0002022</a>",,,"<a href = ""https://www.dsmz.de/catalogues/details/culture/ACC-143.html?tx_dsmzresources_pi5%5BreturnPid%5D=192"" target=""blank"">Leibniz Institute DSMZ ACC 143</a>",Homo sapiens,prostate,,epithelioid,,male,,,,"DOID:0060087, male reproductive benign neoplasm",benign prostate hyperplasia,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=924105""  target=""blank"">COSS924105</a>",,adherent,From MGH/CMT as specified by cell provider: 80% RPMI 1640 + 20% FBS + 20 ng/ml testosterone + 5 microg/ml transferrin + 5 ng/ml sodium selenite + 5 microg/ml insulin + trace elements mix (a list can be provided as they are no longer commercially available in a single mix) split confluent culture 1:3 to 1:8 every 3-7 days using trypsin/EDTA (cells should be incubated for more than 10 min with trypsin/EDTA at 37C); seed out at 0.1 x 10 5 cells/cm 2 ; we noted that the cells grow equally well without the trace element mix which was recommended by the depositor at 37C with 5% CO2 cell harvest of ca. 0.4 x 105 cells/cm 2,,,2012-04-25,2016-04-04
50006,Ca Ski,CaSki,LCL-1541,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002165""  target=""blank"">CLO_0002165</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1550"" target=""blank"">ATCC CRL-1550</a>",Homo sapiens,cervix,,epithelial,,female,,,,"DOID:3744, cervical squamous cell carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=906824""  target=""blank"">COSS906824</a>","STR-PCR Data (source: ECACC):
Amelogenin: X
CSF1PO: 10
D13S317: 8,12
D16S539: 11
D5S818: 13
D7S820: 8,11
THO1: 7
TPOX: 8
vWA: 17",adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 + 2mM Glutamine + 10% Fetal Bovine Serum (FBS). Split confluent cultures 1:3 to 1:6 i.e. seeding at 2-4x10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37C.",,,2012-04-25,2016-07-12
50007,Ca9-22,,LCL-2033,"<a href = ""http://purl.obolibrary.org/obo/CLO_0051380""  target=""blank"">CLO_0051380</a>",,,"<a href = ""http://cellbank.nibiohn.go.jp/~cellbank/en/search_res_det.cgi?ID=470"" target=""blank"">Japanese Collection of Research Bioresources Cell Bank JCRB0625",Homo sapiens,head & neck,,epithelial-like,,male,,,,"DOID:8602, malignant gingival tumor",gingival carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=753538""  target=""blank"">COSS753538</a>",,not specified,From MGH/CMT as specified by cell provider: EMEM w/ 0.6g/l glut and 10% FCS,,,2012-04-25,2016-07-12
50008,CAL-51,,LCL-1472,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002185""  target=""blank"">CLO_0002185</a>",,,"<a href = ""https://www.dsmz.de/catalogues/details/culture/ACC-302.html?tx_dsmzresources_pi5%5BreturnPid%5D=192"" target=""blank"">Leibniz Institute DSMZ ACC 302</a>",Homo sapiens,breast,,epithelial-like,,female,,,,"DOID:3459, breast carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=910927""  target=""blank"">COSS910927</a>",,adherent,From MGH/CMT as specified by cell provider: 80% Dulbecco's MEM (4.5 g/L glucose) + 20% FBS split culture 1:2 once or twice a week using trypsin/EDTA before cells reach complete confluency; seed out at ca. 2 x 106 cells/25 cm 2 ; cells may grow very slowly initially after thawing or after stringent trypsination at 37C with 5-10% CO2 cell harvest of ca. 15-20 x 106 cells/80 cm 2,,,2012-04-25,2016-04-04
50009,Calu-1,,LCL-1580,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002191""  target=""blank"">CLO_0002191</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-54"" target=""blank"">ATCC HTB-54</a>",Homo sapiens,lung,,epithelial,,male,,,,"DOID:3907, epidermoid lung carcinoma",NSCLC epidermoid lung carcinoma,,none,,,"DNA Profile (STR, source: ATCC):
Amelogenin: X 
CSF1PO: 10 
D13S317: 11,12 
D16S539: 11 
D5S818: 10,12 
D7S820: 9,10 
THO1: 9,9.3 
TPOX: 8 
vWA: 15,16",adherent,"From MGH/CMT as specified by cell provider: McCoy's 5a medium (modified) with 1.5 mM L-glutamine adjusted to contain 2.2 g/L sodium bicarbonate, 90%; fetal bovine serum, 10%",,,2012-04-25,2016-07-12
50010,Calu-3,,LCL-1631,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002192""  target=""blank"">CLO_0002192</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-55"" target=""blank"">ATCC HTB-55</a>",Homo sapiens,lung,,epithelial,,male,,,,"DOID:3910, lung adenocarcinoma",NSCLC adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=687777""  target=""blank"">COSS687777</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X 
CSF1PO: 11,12 
D13S317: 12 
D16S539: 12,14 
D5S818: 11 
D7S820: 10,11 
THO1: 6,9.3 
TPOX: 8 
vWA: 16,17",adherent,"From MGH/CMT as specified by cell provider: Minimum essential medium (Eagle) with 2 mM L-glutamine and Earle's BSS adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino acids, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%",,,2012-04-25,2016-04-04
50011,COLO-679,,LCL-1232,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002551""  target=""blank"">CLO_0002551</a>",,,"<a href = ""http://www2.brc.riken.jp/lab/cell/detail.cgi?cell_no=RCB0989&type=1"" target=""blank"">Cell Bank, RIKEN BioResource Center RCB0989</a>",Homo sapiens,skin,,fibroblastic,,female,,,,"DOID:1909, malignant melanoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=906818""  target=""blank"">COSS906818</a>",,adherent,From MGH/CMT as specified by cell provider: 90-95% RPMI 1640 + 5-10% FBS split confluent culture 1:5 to 1:10 using trypsin/EDTA; change medium twice weekly; seed out at ca. 2 x 106 cells/80 cm 2 at 37C with 5% CO2 cell harvest of about 25 x 106 cells/175 cm 2,,,2012-04-25,2016-04-04
50012,COLO-800,,LCL-1233,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002561""  target=""blank"">CLO_0002561</a>",,,"<a href = ""https://www.phe-culturecollections.org.uk/products/celllines/generalcell/detail.jsp?refId=93051123&collection=ecacc_gc"" target=""blank"">European Collection of Cell Cultures (ECACC) 93051123</a>",Homo sapiens,skin,,epithelial-like,,male,,,,"DOID:1909, malignant melanoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=906813""  target=""blank"">COSS906813</a>",,adherent,From MGH/CMT as specified by cell provider: 90-95% RPMI 1640 + 5-10% FBS split confluent culture 1:4 to 1:5 two to three times per week using trypsin/EDTA; seed out at ca. 1-2 x 106 cells/80 cm 2 at 37C with 5% CO2 cell harvest of about 5 x 106 cells/80 cm 2,,,2012-04-25,2016-04-04
50013,FU97,,LCL-1894,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037138""  target=""blank"">CLO_0037138</a>",,,"<a href = ""http://cellbank.nibiohn.go.jp/~cellbank/en/search_res_det.cgi?ID=2962"" target=""blank"">Japanese Collection of Research Bioresources Cell Bank JCRB1074</a>",Homo sapiens,stomach,,epithelial-like,,female,,,,"DOID:5517, stomach carcinoma; DOID:3717, gastric adenocarcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1290806""  target=""blank"">COSS1290806</a>",,adherent,From MGH/CMT as specified by cell provider: Dulbecco's modified Eagle's medium (4.5g/L glucose) with 10% fetal calf serum and 10mg/L insulin,,,2012-04-25,2016-07-12
50014,HEC-1,,LCL-1496,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037162""  target=""blank"">CLO_0037162</a>",,,"<a href = ""http://cellbank.nibiohn.go.jp/~cellbank/en/search_res_det.cgi?ID=229"" target=""blank"">Japanese Collection of Research Bioresources Cell Bank JCRB0042</a>",Homo sapiens,uterus,,,,female,,,,"DOID:363, uterine cancer; DOID:1380, Endometrial cancer; DOID:2871, endometrial carcinoma; DOID:2870, endometrial adenocarcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907051""  target=""blank"">COSS907051</a>",,not specified,JHSF growth medium: Eagle's minimal essential medium with 10% calf serum.,,,2012-04-25,2016-07-12
50015,HLF,,LCL-1938,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009987""  target=""blank"">CLO_0009987</a>",,,"<a href = ""http://cellbank.nibiohn.go.jp/~cellbank/en/search_res_det.cgi?ID=387"" target=""blank"">Japanese Collection of Research Bioresources Cell Bank JCRB0405</a>",Homo sapiens,liver,,,,male,,,,"DOID:684, hepatoma",hepatocellular carcinoma,,none,,,,adherent,From MGH/CMT as specified by cell provider: DMEM w/ 5% FBS,,,2012-04-25,2016-07-12
50016,HUTU-80,HuTu 80,LCL-1150,"<a href = ""http://purl.obolibrary.org/obo/CLO_0004305""  target=""blank"">CLO_0004305</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-40"" target=""blank"">ATCC HTB-40</a>",Homo sapiens,intestine,,epithelial,,male,,,,"DOID:10816, duodenum adenocarcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907073""  target=""blank"">COSS907073</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X,Y 
CSF1PO: 11,13 
D13S317: 8,11 
D16S539: 10,11 
D5S818: 12,13 
D7S820: 9,11 
THO1: 7 
TPOX: 9,11 
vWA: 16,18",adherent,"ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Subculturing: Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37 deg C to facilitate dispersal. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.Add appropriate aliquots of the cell suspension to new culture vessels. Incubate cultures at 37 deg C. Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:5 is recommended.",,,2012-04-25,2016-04-04
50017,IA-LM,,LCL-1778,"<a href = ""http://purl.obolibrary.org/obo/CLO_0050075""  target=""blank"">CLO_0050075</a>",,,"<a href = ""http://www2.brc.riken.jp/lab/cell/detail.cgi?cell_no=RCB0554&type=1"" target=""blank"">Cell Bank, RIKEN BioResource Center RCB0554</a>",Homo sapiens,lung,,,,male,,,,"DOID:4556, lung large cell carcinoma","NSCLC large cell carcinoma, skin met",,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=910779""  target=""blank"">COSS910779</a>",,adherent,,,,2012-04-25,2016-04-04
50018,Ishikawa,,LCL-1497,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037163""  target=""blank"">CLO_0037163</a>",,,"<a href = ""https://www.phe-culturecollections.org.uk/products/celllines/generalcell/detail.jsp?refId=99040201&collection=ecacc_gc"" target=""blank"">European Collection of Cell Cultures (ECACC) 99040201</a>",Homo sapiens,uterus,,epithelial-like,,female,,,,"DOID:363, uterine cancer; DOID:1380, Endometrial cancer; DOID:2871, endometrial carcinoma; DOID:2870, endometrial adenocarcinoma",,,none,,,"STR-PCR Data (source: ECACC):
Amelogenin: X
CSF1PO: 11,12 
D13S317: 9,12
D16S539: 9 
D5S818: 10,11
D7S820: 9,10
THO1: 9,10 
TPOX: 8
vWA: 14,17",adherent,"ECACC growth medium: MEM + 2mM Glutamine + 1% Non Essential Amino Acids (NEAA) + 5% Foetal Bovine Serum (FBS). Subculture routine: Split sub-confluent cultures (70-80%) 1:5  i.e. seeding at 2-4x10,000 cells/cm²  using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37 deg C; cells tend to pile up.",,,2012-04-25,2016-07-12
50019,Ishikawa (Heraklio) 02 ER-,,LCL-1498,"<a href = ""http://purl.obolibrary.org/obo/CLO_0006967""  target=""blank"">CLO_0006967</a>",,,European Collection of Cell Cultures (ECACC) (discontinued),Homo sapiens,uterus,,epithelial,,female,,,,"DOID:363, uterine cancer; DOID:1380, Endometrial cancer; DOID:2871, endometrial carcinoma; DOID:2870, endometrial adenocarcinoma",,,none,,,,not specified,"From MGH/CMT as specified by cell provider: MEM + 10mM glutamine + 1% NEAA + 15% HI-FBS Split confluent cultures 1:8 i.e. seeding at 1-2 x 10,000 cells / cm2 using 0.25% trypsin or trypsin / EDTA; 5% CO2; 37C",,,2012-04-25,2016-07-12
50020,IST-MEL1,,LCL-1234,"<a href = ""http://purl.obolibrary.org/obo/CLO_0006969""  target=""blank"">CLO_0006969</a>",,,"<a href = ""http://wwwsql.iclc.it/mixs_new.php#freeText"" target=""blank"">Interlab Cell Line Collection (ICLC) HTL01006</a>",Homo sapiens,skin,,epithelial-like,,male,,,,"DOID:1909, malignant melanoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907172""  target=""blank"">COSS907172</a>",,adherent,"ICLC growth medium: RPMI 1640 + 10% FBS + 2mM L-Glutamine; Freezing medium: Culture medium + 50% FBS + 10% DMSO; Split confluent cultures 1:2-1:4 using trypsin/EDTA; 37C, 5% CO2, mycoplasma negative, HOECHST and PCR",,,2012-04-25,2016-04-04
50021,JHH-6,,LCL-1923,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009993""  target=""blank"">CLO_0009993</a>",,,"<a href = ""http://cellbank.nibiohn.go.jp/~cellbank/en/search_res_det.cgi?ID=2135"" target=""blank"">Japanese Collection of Research Bioresources Cell Bank JCRB1030</a>",Homo sapiens,liver,,epithelial-like,,female,,,,"DOID:684, hepatocellular carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1240159""  target=""blank"">COSS1240159</a>",,adherent,From MGH/CMT as specified by cell provider: William's E w/ 10% FCS,,,2012-04-25,2016-07-12
50022,KATO III,,LCL-2003,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007073""  target=""blank"">CLO_0007073</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-103"" target=""blank"">ATCC HTB-103</a>",Homo sapiens,stomach,,spherical,,male,,,,DOID:8025; gastric signet ring cell adenocarcinoma,,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907276""  target=""blank"">COSS907276</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X 
CSF1PO: 7,11 
D13S317: 8,12 
D16S539: 10,12 
D5S818: 10,11 
D7S820: 8,12 
THO1: 7,9 
TPOX: 11 
vWA: 14,16","mixed, adherent and suspension","From MGH/CMT as specified by cell provider: Iscove's modified Dulbecco's medium, 80%; fetal bovine serum, 20% - OR - RPMI 1640 medium, 80%; fetal bovine serum, 20%",,,2012-04-25,2016-04-04
50023,KMRC-20,,LCL-1755,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009978""  target=""blank"">CLO_0009978</a>",,,"<a href = ""http://cellbank.nibiohn.go.jp/~cellbank/en/search_res_det.cgi?ID=2959"" target=""blank"">Japanese Collection of Research Bioresources Cell Bank JCRB1071</a>",Homo sapiens,kidney,,epithelial-like,,female,,,,"DOID:4450, renal cell adenocarcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1298169""  target=""blank"">COSS1298169</a>",,not specified,From MGH/CMT as specified by cell provider: Dulbecco's modified Eagle's medium with 10% fetal calf serum,,,2012-04-25,2016-07-12
50024,KYSE-140,,LCL-1547,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007128""  target=""blank"">CLO_0007128</a>",,,"<a href = ""https://www.dsmz.de/catalogues/details/culture/ACC-348.html?tx_dsmzresources_pi5%5BreturnPid%5D=192"" target=""blank"">Leibniz Institute DSMZ ACC 348</a>",Homo sapiens,esophagus,,,,male,,,,"DOID:3748, esophageal squamous cell carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=753573""  target=""blank"">COSS753573</a>",,adherent,"From MGH/CMT as specified by cell provider: 90% RPMI 1640 + 10% FBS split confluent culture 1:5 to 1:10 every 2-4 days using trypsin/EDTA (cells may need five or more minutes to detach from the flask; prior to using trypsin, cells should be washed twice with PBS); seed out at ca. 2-3 x 106 cells/80 cm 2 at 37C with 5% CO2 cell harvest of ca. 20-30 x 10 6 cells/175 cm 2",,,2012-04-25,2016-04-04
50025,KYSE-150,,LCL-1548,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007129""  target=""blank"">CLO_0007129</a>",,,"<a href = ""https://www.dsmz.de/catalogues/details/culture/ACC-375.html?tx_dsmzresources_pi5%5BreturnPid%5D=192"" target=""blank"">Leibniz Institute DSMZ ACC 375</a>",Homo sapiens,esophagus,,epithelioid,,female,,,,"DOID:3748, esophageal squamous cell carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907317""  target=""blank"">COSS907317</a>",,adherent,From MGH/CMT as specified by cell provider: 49% RPMI 1640 + 49% Ham's F12 + 2% FBS split confluent culture 1:20 every 3-4 days using trypsin/EDTA; seed out at ca. 1 x 106 cells/175 cm 2 at 37C with 5% CO2 cell harvest of ca. 1 x 105 cells/cm 2,,,2012-04-25,2016-04-04
50026,KYSE-180,,LCL-1549,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007130""  target=""blank"">CLO_0007130</a>",,,"<a href = ""https://www.dsmz.de/catalogues/details/culture/ACC-379.html?tx_dsmzresources_pi5%5BreturnPid%5D=192"" target=""blank"">Leibniz Institute DSMZ ACC 379</a>",Homo sapiens,esophagus,,epithelioid,,male,,,,"DOID:3748, esophageal squamous cell carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907318""  target=""blank"">COSS907318</a>",,adherent,From MGH/CMT as specified by cell provider: 90% RPMI 1640 + 10% FBS split confluent culture 1:5 to 1:10 every 3-5 days using trypsin/EDTA; seed out at ca. 2-3 x 106 cells/80 cm 2 in 10 ml at 37C with 5% CO2 cell harvest of ca. 30 x 106 cells/175 cm 2,,,2012-04-25,2016-04-04
50027,KYSE-450,,LCL-1550,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007134""  target=""blank"">CLO_0007134</a>",,,"<a href = ""https://www.dsmz.de/catalogues/details/culture/ACC-387.html?tx_dsmzresources_pi5%5BreturnPid%5D=192"" target=""blank"">Leibniz Institute DSMZ ACC 387</a>",Homo sapiens,esophagus,,epithelioid,,male,,,,"DOID:3748, esophageal squamous cell carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907320""  target=""blank"">COSS907320</a>",,adherent,From MGH/CMT as specified by cell provider: 45% RPMI 1640 + 45% Ham's F12 + 10% FBS split confluent culture 1:8 to 1:10 every 3-4 days using trypsin/EDTA; seed out at ca. 1 x 106 cells/25 cm 2 at 37 C with 5% CO2 cell harvest of ca. 5 x 106 cells/25 cm 2,,,2012-04-25,2016-04-04
50028,LNZTA3WT4,LNZTA3p53WT4; WT4,LCL-1345,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007371""  target=""blank"">CLO_0007371</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-11543"" target=""blank"">ATCC CRL-11543</a>",Homo sapiens,brain,,,,unknown,,,,"DOID:3068, glioblastoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1240170""  target=""blank"">COSS1240170</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X,Y 
CSF1PO: 11,12 
D13S317: 11 
D16S539: 9,12 
D5S818: 12 
D7S820: 10,12 
THO1: 9.3 
TPOX: 8,9 
vWA: 15,17",adherent,"From MGH/CMT as specified by cell provider: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose supplemented with 1 microgram/ml tetracycline, 90%; heat-inactivated fetal bovine serum, 10%.
Subculturing: Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:4 to 1:10 is recommended",,,2012-04-25,2016-04-04
50029,MCF7,,LCL-1460,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007606""  target=""blank"">CLO_0007606</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-22"" target=""blank"">ATCC HTB-22</a>",Homo sapiens,breast,,epithelial,,female,,,,"DOID:3458, adenocarcinoma",breast adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905946""  target=""blank"">COSS905946</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X 
CSF1PO: 10 
D13S317: 11 
D16S539: 11,12 
D5S818: 11,12 
D7S820: 8,9 
THO1: 6 
TPOX: 9,12 
vWA: 14,15",adherent,"From MGH/CMT as specified by cell provider: Minimum essential medium (Eagle) with 2 mM L-glutamine and Earle's BSS adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino acids and 1 mM sodium pyruvate and supplemented with 0.01 mg/ml bovine insulin, 90%; fetal bovine serum, 10%.
Protocol: Remove culture medium to a centrifuge tube.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Transfer the cell suspension to the centrifuge tube with the medium and cells from step 1, and centrifuge at approximately 125 x g for 5 to 10 minutes. Discard the supernatant.
Resuspend the cell pellet in fresh growth medium. Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37C.
Subcultivation ratio: A subcultivation ratio of 1:3 to 1:6 is recommended",,,2012-04-25,2016-04-04
50030,MDA-MB-435S,,LCL-1307,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007638""  target=""blank"">CLO_0007638</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-129"" target=""blank"">ATCC HTB-129</a>",Homo sapiens,skin,,melanocyte,,female,,,,"DOID:1909, malignant melanoma (updated based on http://www.atcc.org/products/all/HTB-129.aspx)",,,none,,,"DNA Profile (STR, source: ATCC):
Amelogenin: X 
CSF1PO: 11 
D13S317: 12 
D16S539: 13 
D5S818: 12 
D7S820: 8,10 
THO1: 6,7 
TPOX: 8,11 
vWA: 16,18",adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 2 mM L-glutamine supplemented with 0.01 mg/ml insulin, 90%; fetal bovine serum, 10%.
Protocol: Remove medium, add fresh 0.25%trypsin - 0.053 mM EDTA, rinse and remove. Place flask at room temperature (or incubated at 37C) for approximately 10 minutes or until the cells detach. Add fresh medium, aspirate and dispense into new flasks.
Subcultivation ratio: A subcultivation ratio of 1:3 to 1:6 is recommended",,,2012-04-25,2016-07-12
50031,MT-3,,LCL-1473,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007890""  target=""blank"">CLO_0007890</a>",,,"<a href = ""https://www.dsmz.de/catalogues/details/culture/ACC-403.html?tx_dsmzresources_pi5%5BreturnPid%5D=192"" target=""blank"">Leibniz Institute DSMZ ACC 403</a>",Homo sapiens,breast,,epithelial,,female (probably),,,,"DOID:3459, breast carcinoma",,,none,,,,adherent as colonies,From MGH/CMT as specified by cell provider: 90% RPMI 1640 + 10% FBS + 2 mM L-glutamine + 1 mM sodium pyruvate split confluent culture 1:10 every 4-5 days using trypsin/EDTA; seed out at ca. 1 x 10 6 cells/25 cm 2 at 37C with 5% CO2 cell harvest of ca. 0.4 x 106 cells/cm 2,,,2012-04-25,2016-07-12
50032,NCI-H1648,H1648,LCL-1632,"<a href = ""http://purl.obolibrary.org/obo/CLO_0008006""  target=""blank"">CLO_0008006</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-5882"" target=""blank"">ATCC CRL-5882</a>",Homo sapiens,lung,,,,male,,,,"DOID:3910, lung adenocarcinoma",NSCLC adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=687799""  target=""blank"">COSS687799</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X,Y 
CSF1PO: 10,12 
D13S317: 12 
D16S539: 11 
D5S818: 11 
D7S820: 10,11 
THO1: 7,9.3 
TPOX: 8,11 
vWA: 14,17",adherent,"From MGH/CMT as specified by cell provider: ACL-4 medium (serum-free). ACL-4 medium is formulated at the ATCC as follows:
A 1:1 mixture of Ham's F12 medium with 2.5 mM L-glutamine and Dulbecco's Modified Eagle's Medium adjusted to contain 1.2 g/L sodium bicarbonate (available as ATCC 30-2006) with additional supplements at the concentrations below:
0.02 mg/ml insulin 
0.01 mg/ml transferrin 
25 nM sodium selenite 
50 nM Hydrocortisone 
1 ng/ml Epidermal Growth Factor (do not filter)
0.01 mM ethanolamine 
0.01 mM phosphorylethanolamine 
100 pM triiodothyronine 
0.5% (w/v) bovine serum albumin 
10 mM HEPES 
0.5 mM sodium pyruvate 
2mM L-glutamine",,,2012-04-25,2016-04-04
50033,NCI-H1651,H1651,LCL-1633,"<a href = ""http://purl.obolibrary.org/obo/CLO_0008008""  target=""blank"">CLO_0008008</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-5884"" target=""blank"">ATCC CRL-5884</a>",Homo sapiens,lung,,epithelial,,male,,,,"DOID:3910, lung adenocarcinoma",NSCLC adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=910900""  target=""blank"">COSS910900</a>","DNA Profile (STR, source: ATCC): Amelogenin: X 
CSF1PO: 10,13 
D13S317: 11 
D16S539: 11 
D5S818: 12,14 
D7S820: 8 
THO1: 8 
TPOX: 11 
vWA: 18",adherent,"From MGH/CMT as specified by cell provider: ACL-4 medium supplemented with 10% FBS. ACL-4 medium is formulated at the ATCC as follows:
A 1:1 mixture of Ham's F12 medium with 2.5 mM L-glutamine and Dulbecco's Modified Eagle's Medium adjusted to contain 1.2 g/L sodium bicarbonate (available as ATCC 30-2006) with additional supplements at the concentrations below:
0.02 mg/ml insulin 
0.01 mg/ml transferrin 
25 nM sodium selenite 
50 nM Hydrocortisone 
1 ng/ml Epidermal Growth Factor (do not filter)
0.01 mM ethanolamine 
0.01 mM phosphorylethanolamine 
100 pM triiodothyronine 
0.5% (w/v) bovine serum albumin 
10 mM HEPES 
0.5 mM sodium pyruvate 
2mM L-glutamine",,,2012-04-25,2016-04-04
50034,NCI-H1703,H1703,LCL-1582,"<a href = ""http://purl.obolibrary.org/obo/CLO_0008014""  target=""blank"">CLO_0008014</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-5889"" target=""blank"">ATCC CRL-5889</a>",Homo sapiens,lung,,epithelial,,male,,,,"DOID:3907, lung squamous cell carcinoma",NSCLC squamous cell carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=908474""  target=""blank"">COSS908474</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X,Y 
CSF1PO: 12 
D13S317: 10 
D16S539: 10,12 
D5S818: 11 
D7S820: 10,12 
THO1: 7 
TPOX: 8,11 
vWA: 16,17",adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%",,,2012-04-25,2016-04-04
50035,NCI-H1915,H1915,LCL-1598,"<a href = ""http://purl.obolibrary.org/obo/CLO_0008029""  target=""blank"">CLO_0008029</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-5904"" target=""blank"">ATCC CRL-5904</a>",Homo sapiens,lung,,large cell,,female,,,,"DOID:3908, non-small cell lung carcinoma",NSCLC carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1240184""  target=""blank"">COSS1240184</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium, 90%; fetal bovine serum, 10%",,,2012-04-25,2016-04-04
50036,NCI-H2023,H2023,LCL-1599,"<a href = ""http://purl.obolibrary.org/obo/CLO_0008039""  target=""blank"">CLO_0008039</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-5912"" target=""blank"">ATCC CRL-5912</a>",Homo sapiens,lung,,,,male,,,,"DOID:3908, non-small cell lung carcinoma",NSCLC carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1240187""  target=""blank"">COSS1240187</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X 
CSF1PO: 12 
D13S317: 12 
D16S539: 11,12 
D5S818: 12 
D7S820: 11 
THO1: 7,9 
TPOX: 8 
vWA: 18",not specified,"From MGH/CMT as specified by cell provider: HITES medium supplemented with 5% fetal bovine serum. HITES medium with 5% fetal bovine serum is formulated at the ATCC as follows:
Dulbecco's medium : Ham's F12, 50:50 mix (ATCC 30-2006)
Insulin 0.005 mg/ml
Transferrin 0.01 mg/ml
Sodium selenite 30 nM
Hydrocortisone 10 nM
beta-estradiol 10 nM
HEPES 10 mM
L-glutamine 2 mM (in addition to that in the base medium)
fetal bovine serum 5%",,,2012-04-25,2016-07-12
50037,NCI-H810,H810,LCL-1670,"<a href = ""http://purl.obolibrary.org/obo/CLO_0008117""  target=""blank"">CLO_0008117</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-5816"" target=""blank"">ATCC CRL-5816</a>",Homo sapiens,lung,,epithelial,,male,,,,"DOID:3910, lung adenocarcinoma, DOID:4556, large cell carcinoma",NSCLC giant cell carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=925341""  target=""blank"">COSS925341</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X,Y 
CSF1PO: 10 
D13S317: 12,13 
D16S539: 9 
D5S818: 11 
D7S820: 10 
THO1: 7,9 
TPOX: 10,11 
vWA: 15,16",adherent,"From MGH/CMT as specified by cell provider: HITES medium supplemented with 5% fetal bovine serum.  HITES medium with 5% fetal bovine serum is formulated at the ATCC as follows:
Dulbecco's medium : Ham's F12, 50:50 mix (ATCC 30-2006)
Insulin 0.005 mg/ml
Transferrin 0.01 mg/ml
Sodium selenite 30 nM
Hydrocortisone 10 nM
beta-estradiol 10 nM
HEPES 10 mM
L-glutamine 2 mM (in addition to that in the base medium)
fetal bovine serum 5%",,,2012-04-25,2016-04-04
50038,PC-9,,LCL-1630,"<a href = ""http://purl.obolibrary.org/obo/CLO_0050067""  target=""blank"">CLO_0050067</a>",,,"<a href = ""https://www.phe-culturecollections.org.uk/products/celllines/generalcell/detail.jsp?refId=90071810&collection=ecacc_gc"" target=""blank"">European Collection of Cell Cultures (ECACC) 90071810</a>",Homo sapiens,lung,,,,not specified,,,,DOID:3908; non-small cell lung cancer (disorder),,,none,,,,adherent,From MGH/CMT as specified by cell provider: RPMI 1640 + 10% FBS + PS,,,2012-04-25,2016-04-04
50039,PE/CA-PJ15,,LCL-1212,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009951""  target=""blank"">CLO_0009951</a>",,,"<a href = ""https://www.phe-culturecollections.org.uk/products/celllines/generalcell/detail.jsp?refId=96121230&collection=ecacc_gc"" target=""blank"">European Collection of Cell Cultures (ECACC) 96121230</a>",Homo sapiens,head & neck,,epithelial-like,,unknown,,,,"DOID:1749, DOID:8649, tongue squamous carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1240207""  target=""blank"">COSS1240207</a>",,adherent,"ECACC growth medium: IDMEM + 2mM Glutamine + 10% Foetal Bovine Serum (FBS). Subculture routine: split sub-confluent cultures (70-80%) 1:2 to 1:8 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37 deg C. Note: cells may take up to 7 days to become confluent, a medium change during this period may be required.",,,2012-04-25,2016-07-12
50040,PL4,,LCL-1098,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037112""  target=""blank"">CLO_0037112</a>",,,Cyril Benes (Massachusetts General Hospital),Homo sapiens,pancreas,,,,not specified,,,,"DOID:4905, pancreatic carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1298533""  target=""blank"">COSS1298533</a>",,adherent,,,,2012-04-25,2016-07-12
50041,SJCRH30,RC13; RMS 13; SJRH30,LCL-1408,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037076""  target=""blank"">CLO_0037076</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2061"" target=""blank"">ATCC CRL-2061</a>",Homo sapiens,muscle,,fibroblast,,male,,,,"DOID:3247, rhabdomyosarcoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=909716""  target=""blank"">COSS909716</a>","DNA Profile (STR, source: ATCC):
D5S818: 12, 13 
D13S317: 11 
D7S820: 10 
D16S539: 12 
THO1: 9, 9.3 
TPOX: 8, 11 
vWA: 17, 18 
CSF1PO: 10, 11 
Amelogenin: XY",adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%",,,2012-04-25,2016-07-12
50042,SK-LMS-1,,LCL-1286,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009038""  target=""blank"">CLO_0009038</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-88"" target=""blank"">ATCC HTB-88</a>",Homo sapiens,uterus,,,,female,,,,"DOID:1967, Leiomyosarcoma",sarcoma; leiomyosarcoma uterus,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=909720""  target=""blank"">COSS909720</a>",,adherent,,,,2012-04-25,2016-04-04
50043,SK-MES,SK-MES-1; SK MES 1,LCL-1583,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009049""  target=""blank"">CLO_0009049</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-58"" target=""blank"">ATCC HTB-58</a>",Homo sapiens,lung,,epithelial,,male,,,,"DOID:3907, lung squamous cell carcinoma",NSCLC squamous cell carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=909728""  target=""blank"">COSS909728</a>","STR-PCR Data (source: ECACC):
Amelogenin: X,Y
CSF1PO: 12
D13S317: 11
D16S539: 13
D5S818: 11
D7S820: 8
THO1: 6,9.3
TPOX: 8
vWA: 14",adherent,"From MGH/CMT as specified by cell provider: Ham's F10 : DMEM (1:1) + 2mM Glutamine + 10% Fetal Bovine Serum (FBS). Split confluent cultures 1:2 i.e. seeding at 4-5x10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37C.",,,2012-04-25,2016-04-04
50044,SK-OV-3,,LCL-1517,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009063""  target=""blank"">CLO_0009063</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-77"" target=""blank"">ATCC HTB-77</a>",Homo sapiens,ovary,,epithelial,,female,,,,"DOID:3713, ovarian adenocarcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905959""  target=""blank"">COSS905959</a>","STR-PCR Data (source: ECACC):
Amelogenin: X
CSF1PO: 11 
D13S317: 8,11
D16S539: 12
D5S818: 11 
D7S820: 13,14
THO1: 9,9.3
TPOX: 8,11
vWA: 17,18",adherent,"From MGH/CMT as specified by cell provider: McCoy's 5a + 2mM Glutamine + 15% Fetal Bovine Serum (FBS). Split confluent cultures 1:2 to 1:3 i.e. seeding at 3-6x10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37C.",,,2012-04-25,2016-07-12
50045,SNB75,SNB-75,LCL-1346,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009905""  target=""blank"">CLO_0009905</a>",,,"<a href = ""https://dtp.cancer.gov/repositories/default.htm"" target=""blank"">DTP, DCTD Tumor Repository, National Cancer Institute</a>",Homo sapiens,brain,,,,not specified,,,,"DOID:3068, glioblastoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905982""  target=""blank"">COSS905982</a>",,adherent,,,,2012-04-25,2016-07-12
50046,SW527,SW 527; SW-527,LCL-1474,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009219""  target=""blank"">CLO_0009219</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-7940"" target=""blank"">ATCC CRL-7940</a>",Homo sapiens,breast,,epithelial,,female,,,,"DOID:3459, breast carcinoma",,,none,,,,adherent,"From MGH/CMT as specified by cell provider: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose, 90%; fetal bovine serum, 10%",,,2012-04-25,2016-07-12
50047,SW620,SW-620,LCL-1157,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009221""  target=""blank"">CLO_0009221</a>",,,"<a href = ""http://www.atcc.org/Products/All/CCL-227"" target=""blank"">ATCC CCL-227</a>",Homo sapiens,intestine,,epithelial,,male,,,,"DOID:1520, colon carcinoma","colon adenocarcinoma, Dukes' type C",,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905962""  target=""blank"">COSS905962</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X 
CSF1PO: 13,14 
D13S317: 12 
D16S539: 9,13 
D5S818: 13 
D7S820: 8,9 
THO1: 8 
TPOX: 11 
vWA: 16",adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 2 mM L-glutamine, 90%; fetal bovine serum, 10%",,,2012-04-25,2016-04-04
50048,T24,T-24,LCL-1709,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009245""  target=""blank"">CLO_0009245</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-4"" target=""blank"">ATCC HTB-4</a>",Homo sapiens,urinary bladder,,epithelial,,female,,,,"DOID:4007, bladder carcinoma; DOID:4006, bladder transitional cell carcinoma",transitional cell carcinoma; urothelial bladder carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=724812""  target=""blank"">COSS724812</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X 
CSF1PO: 10,12 
D13S317: 12 
D16S539: 9 
D5S818: 10,12 
D7S820: 10,11 
THO1: 6 
TPOX: 8,11 
vWA: 17",adherent,"From MGH/CMT as specified by cell provider: McCoy's 5a medium (modified) with 1.5 mM L-glutamine adjusted to contain 2.2 g/L sodium bicarbonate, 90%; fetal bovine serum, 10%.
Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:3 to 1:8 is recommended",,,2012-04-25,2016-07-12
50049,WiDr,,LCL-1169,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009600""  target=""blank"">CLO_0009600</a>",,,"<a href = ""http://www.atcc.org/Products/All/CCL-218"" target=""blank"">ATCC CCL-218</a>",Homo sapiens,intestine,,epithelial,,female,,,,"DOID:1520, DOID:234, colon adenocarcinoma",,,none,,,"STR-PCR Data (source: ECACC):
Amelogenin: X
CSF1PO: 11,12
D13S317: 11,12
D16S539: 11,12
D5S818: 11,12 
D7S820: 10 
THO1: 6,9
TPOX: 8,9
vWA: 17,19",adherent,"From MGH/CMT as specified by cell provider: EMEM (EBSS) + 2mM Glutamine + 1% Non Essential Amino Acids (NEAA) + 10% Fetal Bovine Serum (FBS). Split confluent cultures 1:5 to 1:10 i.e. seeding at 1-2x10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37C.",,,2012-04-25,2016-07-12
50056,HME1,hTERT-HME1,LCL-2083,"<a href = ""http://purl.obolibrary.org/obo/CLO_0004291""  target=""blank"">CLO_0004291</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-4010"" target=""blank"">ATCC CRL-4010</a>",Homo sapiens,breast,,epithelial,,female,,,,not diseased,,"Human mammary epithelium, HME1 cell line, was derived from a 53-year-old patient undergoing reduction mammoplasty surgery (no history of breast cancer). 
The HME1 cells were immortalized by infection with the retrovirus pBabepuro+hTERT vector and cultured in complete growth medium containing puromycin until stable clones were selected.",pBabepuro+hTERT integration,,,"DNA Profile (STR, source: ATCC): 
Amelogenin: X 
CSF1PO: 10 
D13S317: 11,12 
D16S539: 11,12 
D5S818: 11 
D7S820: 7,12 
THO1: 7,8 
TPOX: 10,12 
vWA: 15,16",adherent,"ATCC complete growth medium: The base medium for this cell line (MEBM) along with all the additives can be obtained from Lonza/Clonetics Corporation as a kit: MEGM, Kit Catalog No. CC-3150. ATCC does not use the GA-1000 (gentamycin-amphotericin B mix) provided with kit. Note: Do not filter complete medium
Atmosphere: air, 95%; carbon dioxide (CO2), 5% 
Temperature: 37.0 deg C

Subculturing protocol:
Remove and discard culture medium.
Add 2.0 to 3.0 ml of 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to the flask and observe cells under an inverted microscope until the cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal.
To remove trypsin-EDTA solution, add 2.0 to 3.0 ml of 0.1% SoybeanTrypsin Inhibitor solution and aspirate cells by gently pipetting.
Transfer cell suspension to a 15 mL centrifuge tube and spin at approximately 125 x g for 5 to 10 minutes.
Discard supernatant and resuspend cells in fresh growth medium. Add appropriate aliquots of the cell suspension to new culture vessels. An inoculum of 7 X 10(3) to 9 X 10(3) viable cells/sq. cm is recommended. Subculture cultures when they reach a cell concentration between 4 X 10(4) and 6 X 10(4) cells/sq. cm.
Incubate cultures at 37C.
Interval: weekly 
Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:6 is recommended. 
Medium Renewal: Every 2 to 3 days",,,2012-05-01,2016-07-12
50057,SK-BR-3,SKBr3,LCL-1475,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009034""  target=""blank"">CLO_0009034</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-30"" target=""blank"">ATCC HTB-30</a>",Homo sapiens,breast,,epithelial,,female,,,,"DOID:3459, breast carcinoma",,,none,,,"DNA Profile (STR, source: ATCC): 
Amelogenin: X 
CSF1PO: 12 
D13S317: 11,12 
D16S539: 9 
D5S818: 9,12 
D7S820: 9,12 
THO1: 8,9 
TPOX: 8,11 
vWA: 17",adherent,"ATCC complete growth medium: The base medium for this cell line is ATCC-formulated McCoy's 5a Medium Modified, Catalog No. 30-2007. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 95%; carbon dioxide (CO2), 5% 
Temperature: 37.0 deg C

Subculturing protocol:
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin, 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37 deg C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37 deg C.
Subcultivation Ratio: A subcultivation ratio of 1:2 is recommended 
Medium Renewal: 2 to 3 times per week",,,2012-05-01,2016-07-12
50058,MDA-MB-231,MDAMB231; MDA-MB231,LCL-1461,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007634""  target=""blank"">CLO_0007634</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-26"" target=""blank"">ATCC HTB-26</a>",Homo sapiens,breast,,epithelial,,female,,,,"DOID:3458, adenocarcinoma",breast adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905960""  target=""blank"">COSS905960</a>","DNA Profile (STR, source: ATCC): 
Amelogenin: X 
CSF1PO: 12,13 
D13S317: 13 
D16S539: 12 
D5S818: 12 
D7S820: 8,9 
THO1: 7,9.3 
TPOX: 8,9 
vWA: 15,18",adherent,"ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Leibovitz's L-15 Medium, Catalog No. 30-2008. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 100% 
Temperature: 37.0 deg C

Subculturing protocol:
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37 deg C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37 deg C without CO2.
Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended 
Medium Renewal: 2 to 3 times per week",,,2012-05-01,2016-07-12
50060,A-375,A375,LCL-1235,"<a href = ""http://purl.obolibrary.org/obo/CLO_0001582""  target=""blank"">CLO_0001582</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1619"" target=""blank"">ATCC CRL-1619</a>",Homo sapiens,skin,,epithelial,,female,,,,"DOID:1909, malignant melanoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=906793""  target=""blank"">COSS906793</a>","DNA Profile (STR, source: ATCC): 
Amelogenin: X 
CSF1PO: 11,12 
D13S317: 11,14 
D16S539: 9 
D5S818: 12 
D7S820: 9 
THO1: 8 
TPOX: 8,10 
vWA: 16,17",adherent,"ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0 deg C

Subculturing protocol:
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37 deg C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37 deg C.
Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended 
Medium Renewal: Every 2 to 3 days",,,2012-05-01,2016-07-12
50061,HeLa,,LCL-1512,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003684""  target=""blank"">CLO_0003684</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRM-CCL-2"" target=""blank"">ATCC CRM-CCL-2</a>",Homo sapiens,cervix,,epithelial,,female,,,,"DOID:3702, cervical adenocarcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1298134""  target=""blank"">COSS1298134</a>","DNA Profile (STR, source: ATCC):
Amelogenin: X 
CSF1PO: 9,10 
D13S317: 12,13.3 
D16S539: 9,10 
D5S818: 11,12 
D7S820: 8,12 
THO1: 7 
TPOX: 8,12 
vWA: 16,18",adherent,"ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 95%; carbon dioxide (CO2), 5% 
Temperature: 37.0 deg C

Subculturing protocol:
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37 deg C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37 deg C.

Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:6 is recommended 
Medium Renewal: 2 to 3 times per week",,,2012-05-01,2016-07-12
50084,A549,,LCL-1601,"<a href = ""http://purl.obolibrary.org/obo/CLO_0001601""  target=""blank"">CLO_0001601</a>",,,"<a href = ""http://www.atcc.org/Products/All/CCL-185"" target=""blank"">ATCC CCL-185</a>",Homo sapiens,lung,,,,male,,,,"DOID:3908, non-small cell lung carcinoma",NSCLC carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905949""  target=""blank"">COSS905949</a>",,adherent,"From MGH/CMT as specified by cell provider: Ham's F12K medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 90%; fetal bovine serum, 10%",,,2012-07-31,2016-04-04
50091,AU565,AU-565,LCL-1462,"<a href = ""http://purl.obolibrary.org/obo/CLO_0001769""  target=""blank"">CLO_0001769</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2351"" target=""blank"">ATCC CRL-2351</a>",Homo sapiens,breast,,,,female,,,,"DOID:3458, adenocarcinoma",breast adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=910704""  target=""blank"">COSS910704</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Subculturing: Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:4 to 1:6 is recommended",,,2012-07-31,2016-04-04
50105,BT-20,,LCL-1476,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002041""  target=""blank"">CLO_0002041</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-19"" target=""blank"">ATCC HTB-19</a>",Homo sapiens,breast,,,,female,,,,"DOID:3459, breast carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=906801""  target=""blank"">COSS906801</a>",,adherent,"From MGH/CMT as specified by cell provider: Minimum essential medium (Eagle) with 2 mM L-glutamine and Earle's BSS adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino acids, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:4 is recommended",,,2012-07-31,2016-04-04
50106,BT-474,,LCL-1308,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002042""  target=""blank"">CLO_0002042</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-20"" target=""blank"">ATCC HTB-20</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=946359""  target=""blank"">COSS946359</a>",,adherent,"From MGH/CMT as specified by cell provider: Hybri-Care Medium ATCC 46-X, 90%; fetal bovine serum, 10%.
Protocol: Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:3 is recommended",,,2012-07-31,2016-04-04
50107,BT-483,,LCL-1309,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002043""  target=""blank"">CLO_0002043</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-121"" target=""blank"">ATCC HTB-121</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=949093""  target=""blank"">COSS949093</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 0.01 mg/ml bovine insulin, 80%; fetal bovine serum, 20%.
Protocol: Remove medium, add fresh 0.25% trypsin, 0.53 mM EDTA solution for 3 to 5 minutes, remove trypsin and let the culture sit at 37C for 3 to 5 minutes. Add fresh medium, aspirate and dispense into new flasks.
Subcultivation ratio: A subcultivation ratio of 1:2 is recommended",,,2012-07-31,2016-04-04
50108,BT-549,,LCL-1310,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002044""  target=""blank"">CLO_0002044</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-122"" target=""blank"">ATCC HTB-122</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905951""  target=""blank"">COSS905951</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate supplemented with 0.023 IU/ml insulin and 10% fetal bovine serum.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:6 is recommended",,,2012-07-31,2016-04-04
50112,C32,,LCL-1238,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002113""  target=""blank"">CLO_0002113</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1585"" target=""blank"">ATCC CRL-1585</a>",Homo sapiens,skin,,,,male,,,,"DOID:1909, malignant melanoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=906830""  target=""blank"">COSS906830</a>",,adherent,"From MGH/CMT as specified by cell provider: Minimum essential medium (Eagle) with 2 mM L-glutamine and Earle's BSS adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino acids, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%",,,2012-07-31,2016-04-04
50131,CAMA-1,,LCL-1466,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002194""  target=""blank"">CLO_0002194</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-21"" target=""blank"">ATCC HTB-21</a>",Homo sapiens,breast,,,,female,,,,"DOID:3458, adenocarcinoma",breast adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=946382""  target=""blank"">COSS946382</a>",,adherent,"From MGH/CMT as specified by cell provider: Minimum essential medium (Eagle) with 2 mM L-glutamine and Earle's BSS adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino acids, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:3 to 1:4 is recommended",,,2012-07-31,2016-04-04
50149,COLO 858,,LCL-1242,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002569""  target=""blank"">CLO_0002569</a>",,,"<a href = ""https://www.phe-culturecollections.org.uk/products/celllines/generalcell/detail.jsp?refId=93052613&collection=ecacc_gc"" target=""blank"">European Collection of Cell Cultures (ECACC) 93052613</a>",Homo sapiens,skin,,,,male,,,,"DOID:1909, malignant melanoma",,,none,,,,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 + 2mM Glutamine + 10% Fetal Bovine Serum (FBS). Split confluent cultures 1:3 to 1:6 i.e. seeding at 2-4x10,000 cells/cm2 using 0.25% trypsin/EDTA; 37C; 5% CO2.",,,2012-07-31,2016-07-12
50205,HCC1143,,LCL-1329,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003630""  target=""blank"">CLO_0003630</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2321"" target=""blank"">ATCC CRL-2321</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, primary ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=749710""  target=""blank"">COSS749710</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: Remove medium, rinse with 0.25% trypsin, 0.53 mM EDTA solution, add an additional 1 to 2 ml of trypsin solution and allow the flask to set at room temperature (or incubate at 37C) until cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:4 is recommended",,,2012-07-31,2016-04-04
50206,HCC1395,HCC-1395,LCL-1330,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003634""  target=""blank"">CLO_0003634</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2324"" target=""blank"">ATCC CRL-2324</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, primary ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=749712""  target=""blank"">COSS749712</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:2 is recommended",,,2012-07-31,2016-04-04
50207,HCC1419,HCC-1419,LCL-1314,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003636""  target=""blank"">CLO_0003636</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2326"" target=""blank"">ATCC CRL-2326</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907045""  target=""blank"">COSS907045</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Growth Conditions: The line grows as large epithelial attached cells in island-like formation. 
Subculturing: Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37C.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:3 is recommended",,,2012-07-31,2016-04-04
50208,HCC1428,HCC-1428,LCL-1467,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003637""  target=""blank"">CLO_0003637</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2327"" target=""blank"">ATCC CRL-2327</a>",Homo sapiens,breast,,,,female,,,,"DOID:3458, adenocarcinoma",breast adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1290905""  target=""blank"">COSS1290905</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:4 to 1:8 is recommended",,,2012-07-31,2016-04-04
50210,HCC1569,HCC-1569,LCL-1480,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003640""  target=""blank"">CLO_0003640</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2330"" target=""blank"">ATCC CRL-2330</a>",Homo sapiens,breast,,,,female,,,,"DOID:3459, breast carcinoma",breast carcinoma; metastatic carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907046""  target=""blank"">COSS907046</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Subculturing: Remove medium, rinse with 0.25% trypsin, 0.03% EDTA solution, add an additional 1 to 2 ml of trypsin solution and allow the flask to set at room temperature (or incubate at 37C) until cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:4 to 1:6 is recommended",,,2012-07-31,2016-04-04
50211,HCC1806,HCC-1806,LCL-1960,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003644""  target=""blank"">CLO_0003644</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2335"" target=""blank"">ATCC CRL-2335</a>",Homo sapiens,breast,,,,female,,,,"DOID:7459, primary acantholytic squamous cell carcino",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907047""  target=""blank"">COSS907047</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Subculturing: Remove medium, rinse with 0.25% trypsin, 0.03% EDTA solution, add an additional 1 to 2 ml of trypsin solution and allow the flask to set at room temperature (or incubate at 37C) until cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:4 is recommended",,,2012-07-31,2016-04-04
50212,HCC1937,HCC-1937,LCL-1331,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003645""  target=""blank"">CLO_0003645</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2336"" target=""blank"">ATCC CRL-2336</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, primary ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=749714""  target=""blank"">COSS749714</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: Remove medium, rinse with 0.25% trypsin, 0.03% EDTA solution, add an additional 1 to 2 ml of trypsin solution and allow the flask to set at room temperature (or incubate at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:4 is recommended",,,2012-07-31,2016-04-04
50213,HCC1954,HCC-1954,LCL-1332,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003647""  target=""blank"">CLO_0003647</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2338"" target=""blank"">ATCC CRL-2338</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, primary ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=749709""  target=""blank"">COSS749709</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:4 to 1:8 is recommended",,,2012-07-31,2016-04-04
50214,HCC202,HCC-202,LCL-1333,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003649""  target=""blank"">CLO_0003649</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2316"" target=""blank"">ATCC CRL-2316</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, primary ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1290906""  target=""blank"">COSS1290906</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Subculturing: Remove medium, rinse with 0.25% trypsin, 0.03% EDTA solution, add an additional 1 to 2 ml of trypsin solution and allow the flask to set at room temperature (or incubate at 37C) until cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:3 is recommended",,,2012-07-31,2016-04-04
50216,HCC38,HCC-38,LCL-1334,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003655""  target=""blank"">CLO_0003655</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2314"" target=""blank"">ATCC CRL-2314</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, primary ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=749717""  target=""blank"">COSS749717</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:4 is recommended",,,2012-07-31,2016-04-04
50219,HCC70,HCC-70,LCL-1335,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003658""  target=""blank"">CLO_0003658</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2315"" target=""blank"">ATCC CRL-2315</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, primary ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=907048""  target=""blank"">COSS907048</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:4 to 1:6 is recommended",,,2012-07-31,2016-04-04
50238,Hs 578T,Hs-578-T,LCL-1315,"<a href = ""http://purl.obolibrary.org/obo/CLO_0004009""  target=""blank"">CLO_0004009</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-126"" target=""blank"">ATCC HTB-126</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905957""  target=""blank"">COSS905957</a>",,adherent,"From MGH/CMT as specified by cell provider: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose and supplemented with 0.01 mg/ml bovine insulin and 10% fetal bovine serum.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:3 to 1:8 is recommended",,,2012-07-31,2016-07-12
50324,MB 157,,LCL-1484,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007544""  target=""blank"">CLO_0007544</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-7721"" target=""blank"">ATCC CRL-7721</a>",Homo sapiens,breast,,,,female,,,,"DOID:3459, breast carcinoma",,,none,,,,adherent,"From MGH/CMT as specified by cell provider: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 90%; fetal bovine serum, 10%.
Protocol: Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: 1:2 to 1:3",,,2012-07-31,2016-07-12
50327,MDA-MB-134-VI,,LCL-1316,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007631""  target=""blank"">CLO_0007631</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-23"" target=""blank"">ATCC HTB-23</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,,,lightly adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 2 mM L-glutamine, 80%; fetal bovine serum, 20%.
Protocol: Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:4 is recommended",,,2012-07-31,2016-07-12
50328,MDA-MB-157,,LCL-1916,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007632""  target=""blank"">CLO_0007632</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-24"" target=""blank"">ATCC HTB-24</a>",Homo sapiens,breast,,,,female,,,,"DOID:5605, breast medullary carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=925338""  target=""blank"">COSS925338</a>",,adherent,"From MGH/CMT as specified by cell provider: LLeibovitz's L-15 medium with 2 mM L-glutamine, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37C without CO2.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:3 is recommended",,,2012-07-31,2016-04-04
50329,MDA-MB-175-VII,,LCL-1317,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007633""  target=""blank"">CLO_0007633</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-25"" target=""blank"">ATCC HTB-25</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=908120""  target=""blank"">COSS908120</a>",,adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 2 mM L-glutamine, 90%; fetal bovine serum, 10%.
Protocol: 
Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:6 is recommended",,,2012-07-31,2016-04-04
50331,MDA-MB-361,,LCL-1468,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007636""  target=""blank"">CLO_0007636</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-27"" target=""blank"">ATCC HTB-27</a>",Homo sapiens,breast,,,,female,,,,"DOID:3458, adenocarcinoma",breast adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=908121""  target=""blank"">COSS908121</a>",,adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 2 mM L-glutamine, 80%; fetal bovine serum, 20%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:6 is recommended",,,2012-07-31,2016-04-04
50332,MDA-MB-415,,LCL-1469,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007637""  target=""blank"">CLO_0007637</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-128"" target=""blank"">ATCC HTB-128</a>",Homo sapiens,breast,,,,female,,,,"DOID:3458, adenocarcinoma",breast adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=924240""  target=""blank"">COSS924240</a>",,adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 2mM L-glutamine supplemented with 10 mcg/ml insulin and 10 mcg/ml glutathione, 85%; fetal bovine serum, 15%.
Protocol: Subcultures are prepared by scraping. Remove old medium, add fresh, dislodge cells, aspirate and dispense into new flasks. Subculture every 6 to 8 days.
Subcultivation ratio: A subcultivation ratio of 1:2 is recommended",,,2012-07-31,2016-04-04
50333,MDA-MB-436,,LCL-1470,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007639""  target=""blank"">CLO_0007639</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-130"" target=""blank"">ATCC HTB-130</a>",Homo sapiens,breast,,,,female,,,,"DOID:3458, adenocarcinoma",breast adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1240172""  target=""blank"">COSS1240172</a>",,adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 10 mcg/ml insulin, 16 mcg/ml glutathione, 90%; fetal bovine serum, 10%.
Subculturing: Subcultures are prepared by scraping. Remove spent medium, add 3 to 5 ml of fresh medium, dislodge cells from the floor of the flask, aspirate and dispense into new flasks. Subculture every 6 to 8 days.
Subcultivation ratio: A subcultivation ratio of 1:2 is recommended",,,2012-07-31,2016-04-04
50334,MDA-MB-453,,LCL-1485,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007640""  target=""blank"">CLO_0007640</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-131"" target=""blank"">ATCC HTB-131</a>",Homo sapiens,breast,,,,female,,,,"DOID:3459, breast carcinoma",breast carcinoma; metastatic carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=908122""  target=""blank"">COSS908122</a>",,adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 2 mM L-glutamine, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C without CO2.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:6 is recommended",,,2012-07-31,2016-04-04
50335,MDA-MB-468,,LCL-1471,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007641""  target=""blank"">CLO_0007641</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-132"" target=""blank"">ATCC HTB-132</a>",Homo sapiens,breast,,,,female,,,,"DOID:3458, adenocarcinoma",breast adenocarcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=908123""  target=""blank"">COSS908123</a>",,adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 2 mM L-glutamine, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:4 is recommended",,,2012-07-31,2016-04-04
50454,PC-3,PC3,LCL-1299,"<a href = ""http://purl.obolibrary.org/obo/CLO_0008395""  target=""blank"">CLO_0008395</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1435"" target=""blank"">ATCC CRL-1435</a>",Homo sapiens,prostate,,,,male,,,,"DOID:2526, Prostate adenocarcinoma",prostate adenocarcinoma; bone metastasis,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905934""  target=""blank"">COSS905934</a>",,adherent,,,,2012-07-31,2016-04-04
50475,RVH-421,,LCL-1255,"<a href = ""http://purl.obolibrary.org/obo/CLO_0008902""  target=""blank"">CLO_0008902</a>",,,"<a href = ""https://www.dsmz.de/catalogues/details/culture/ACC-127.html?tx_dsmzresources_pi5%5BreturnPid%5D=192"" target=""blank"">Leibniz Institute DSMZ ACC 127</a>",Homo sapiens,skin,,,,male,,,,"DOID:1909, malignant melanoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=909706""  target=""blank"">COSS909706</a>",,adherent,From MGH/CMT as specified by cell provider: 90% RPMI 1640 (or Leibovitz's L-15) + 10% FBS split confluent culture up to 1:10 one to two times per week using trypsin/EDTA; seed out 1-2 x 106 cells/175 cm 2 at 37C with 5% CO2 about 15 x 106 cells/175 cm 2,,,2012-07-31,2016-04-04
50541,T47D,T-47D,LCL-1486,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009251""  target=""blank"">CLO_0009251</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-133"" target=""blank"">ATCC HTB-133</a>",Homo sapiens,breast,,,,female,,,,"DOID:3459, breast carcinoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905945""  target=""blank"">COSS905945</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 or DMEM + 2mM Glutamine + 10% Fetal Bovine Serum (FBS). Split confluent cultures 1:3 to 1:6 i.e. seeding at 2-4x10,000 cells/cm2 using 0.25% trypsin or trypsin or trypsin/EDTA; 5% CO2; 37C.",,,2012-07-31,2016-07-12
50556,UACC-812,,LCL-1319,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009467""  target=""blank"">CLO_0009467</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1897"" target=""blank"">ATCC CRL-1897</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=910910""  target=""blank"">COSS910910</a>",,adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 2 mM L-glutamine supplemented with 20 ng/ml human EGF and 20% fetal bovine serum.
Growth Conditions: The cells grow very slowly, and growth is enhanced by using 20% fetal bovine serum and adding epidermal growth factor (20 ng/ml) to the medium.
Protocol:
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:3 is recommended",,,2012-07-31,2016-04-04
50557,UACC-893,,LCL-1320,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009468""  target=""blank"">CLO_0009468</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1902"" target=""blank"">ATCC CRL-1902</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=909778""  target=""blank"">COSS909778</a>",,adherent,"From MGH/CMT as specified by cell provider: Leibovitz's L-15 medium with 2 mM L-glutamine, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37C.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:3 is recommended",,,2012-07-31,2016-04-04
50567,WM-115,,LCL-1260,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009613""  target=""blank"">CLO_0009613</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1675"" target=""blank"">ATCC CRL-1675</a>",Homo sapiens,skin,,,,female,,,,"DOID:1909, malignant melanoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=909784""  target=""blank"">COSS909784</a>",,adherent,"From MGH/CMT as specified by cell provider: Minimum essential medium (Eagle) with 2 mM L-glutamine and Earle's BSS adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino acids, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.03% EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 34 to 35°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 34 to 35°C.
Subcultivation ratio: A subcultivation ratio of 1:3 to 1:6 is recommended",,,2012-07-31,2016-04-04
50568,WM1552C,,LCL-1261,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009614""  target=""blank"">CLO_0009614</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2808"" target=""blank"">ATCC CRL-2808</a>",Homo sapiens,skin,,,,male,,,,"DOID:1909, malignant melanoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1299078""  target=""blank"">COSS1299078</a>",,adherent,"From MGH/CMT as specified by cell provider: 2% Tumor Medium (Tu2%) containing a 4:1 mixture of MCDB 153 medium with 1.5 g/L sodium bicarbonate and Leibovitz's L-15 medium with 2 mM L-glutamine supplemented with 0.005 mg/ml bovine insulin, 1.68 mM CaCl2, and 2% fetal bovine serum.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels. 
An inoculum of 5 X 10(3) to 7 X 10(3) viable cells/cm2 is recommended. .
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation of 1:3 to 1:4 is recommended",,,2012-07-31,2016-04-04
50574,ZR-75-1,,LCL-1321,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009727""  target=""blank"">CLO_0009727</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1500"" target=""blank"">ATCC CRL-1500</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,,,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:4 to 1:6 is recommended",,,2012-07-31,2016-07-12
50575,ZR-75-30,,LCL-1322,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009728""  target=""blank"">CLO_0009728</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1504"" target=""blank"">ATCC CRL-1504</a>",Homo sapiens,breast,,,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=909907""  target=""blank"">COSS909907</a>",,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate, 90%; fetal bovine serum, 10%.
Protocol: 
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37°C.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:3 is recommended",,,2012-07-31,2016-04-04
50576,184B5,,LCL-2081,"<a href = ""http://purl.obolibrary.org/obo/CLO_0001138""  target=""blank"">CLO_0001138</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-8799"" target=""blank"">ATCC CRL-8799</a>",Homo sapiens,breast,,epithelial,,female,,,,not diseased,,"Cells derived from the tissue were exposed to benzo(a)pyrene, and a transformed line was established. The 184B5 cell line was established from normal mammary tissue obtained from a normal reduction mammoplasty.",none,,,,adherent,,,,2012-11-02,2016-04-04
50577,DU4475,,LCL-1323,"<a href = ""http://purl.obolibrary.org/obo/CLO_0002842""  target=""blank"">CLO_0002842</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-123"" target=""blank"">ATCC HTB-123</a>",Homo sapiens,breast,,epithelial,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=906844""  target=""blank"">COSS906844</a>",,suspension,,,,2012-11-02,2016-04-04
50578,HCC1187,,LCL-1324,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003632""  target=""blank"">CLO_0003632</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2322"" target=""blank"">ATCC CRL-2322</a>",Homo sapiens,breast,duct,epithelial,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=749711""  target=""blank"">COSS749711</a>",,"mixed, adherent and suspension",,,,2012-11-02,2016-07-12
50579,HCC1500,,LCL-1325,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003639""  target=""blank"">CLO_0003639</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2329"" target=""blank"">ATCC CRL-2329</a>",Homo sapiens,breast,duct,epithelial,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1303900""  target=""blank"">COSS1303900</a>",,adherent,,,,2012-11-02,2016-04-04
50580,HCC1599,,LCL-1326,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003641""  target=""blank"">CLO_0003641</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2331"" target=""blank"">ATCC CRL-2331</a>",Homo sapiens,breast,duct,epithelial,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=749713""  target=""blank"">COSS749713</a>",,suspension,,,,2012-11-02,2016-04-04
50581,HCC2157,,LCL-1327,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003650""  target=""blank"">CLO_0003650</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2340"" target=""blank"">ATCC CRL-2340</a>",Homo sapiens,breast,duct,epithelial,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=749715""  target=""blank"">COSS749715</a>",,suspension,,,,2012-11-02,2016-04-04
50582,HCC2218,,LCL-1328,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003652""  target=""blank"">CLO_0003652</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2343"" target=""blank"">ATCC CRL-2343</a>",Homo sapiens,breast,duct,epithelial,,female,,,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=749716""  target=""blank"">COSS749716</a>",,suspension,,,,2012-11-02,2016-04-04
50583,MCF 10A,,LCL-2085,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007599""  target=""blank"">CLO_0007599</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-10317"" target=""blank"">ATCC CRL-10317</a>",Homo sapiens,breast,,epithelial,,female,,,,fibrocystic disease,non-tumorigenic,,none,,,,adherent,,,,2012-11-02,2016-04-04
50584,MCF 10F,,LCL-2102,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007600""  target=""blank"">CLO_0007600</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-10318"" target=""blank"">ATCC CRL-10318</a>",Homo sapiens,breast,,epithelial,,female,,,,fibrocystic disease,non-tumorigenic,,none,,,,adherent,,,,2012-11-02,2016-04-04
50811,Ramos (RA 1),,LCL-1097,"<a href = ""http://purl.obolibrary.org/obo/CLO_0008739""  target=""blank"">CLO_0008739</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1596"" target=""blank"">ATCC CRL-1596</a>",Homo sapiens,blood,,,,male,,,,Burkitt's lymphoma,,,none,,,,suspension,,,,2012-12-17,2016-07-12
50861,THP-1,,LCL-1072,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009348""  target=""blank"">CLO_0009348</a>",,,"<a href = ""http://www.atcc.org/Products/All/TIB-202"" target=""blank"">ATCC TIB-202</a>",Homo sapiens,blood,,,,male,,,,AML,,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=909771""  target=""blank"">COSS909771</a>",,suspension,,,,2012-12-17,2016-07-12
50868,U-87 MG,U-87-MG,LCL-1364,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009464""  target=""blank"">CLO_0009464</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-14"" target=""blank"">ATCC HTB-14</a>",Homo sapiens,brain,,,,female,,,,"DOID:3068, glioblastoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=687590""  target=""blank"">COSS687590</a>",,adherent,,,,2012-12-17,2016-07-12
50869,U-937,,LCL-1125,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009465""  target=""blank"">CLO_0009465</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-1593.2.aspx"" target=""blank"">ATCC CRL-1593.2</a>",Homo sapiens,lymphatic system,,,,male,,,,"DOID:0050745, diffuse large B-cell lymphoma, DOID:0060060, non-Hodgkin's lymphoma; DOID:707, B-cell lymphocytic neoplasm",histiocytic lymphoma,,none,,,,suspension,,,,2012-12-17,2016-07-12
50988,LOXIMVI,LOX IMVI,LCL-1276,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037130""  target=""blank"">CLO_0037130</a>",,,"<a href = ""https://dtp.cancer.gov/repositories/default.htm"" target=""blank"">DTP, DCTD Tumor Repository, National Cancer Institute</a>",Homo sapiens,skin,,,,male,,,,"DOID:1909, malignant melanoma",malignant melanoma; metastatic,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905974""  target=""blank"">COSS905974</a>",,semi-adherent,,,,2012-07-31,2016-07-12
50999,MMAC-SF,,LCL-1277,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037131""  target=""blank"">CLO_0037131</a>",,,"<a href = ""http://www2.brc.riken.jp/lab/cell/detail.cgi?cell_no=RCB1200&type=1"" target=""blank"">Cell Bank, RIKEN BioResource Center RCB1200</a>",Homo sapiens,skin,,,,na,,,,"DOID:1909, malignant melanoma",malignant melanoma; ascites,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=925339""  target=""blank"">COSS925339</a>",,adherent,,,,2012-07-31,2016-07-12
51006,MZ7-mel,,LCL-1279,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037133""  target=""blank"">CLO_0037133</a>",,,Thomas Woelfel (Johannes Gutenberg University Mainz),Homo sapiens,skin,,,,female,,,,"DOID:1909, malignant melanoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=753596""  target=""blank"">COSS753596</a>",,adherent,,,,2012-07-31,2016-07-12
51081,SUM1315MO2,SUM-1315MO2,LCL-2066,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009916""  target=""blank"">CLO_0009916</a>",,,University of Michigan (http://www.cancer.med.umich.edu/breast_cell/Production/index.html),Homo sapiens,breast,,,,,,,,,,,none,,,,not specified,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/10604729""  target=""blank"">PMID 10604729</a>",,2013-07-30,2016-07-12
51082,SUM149PT,SUM-149PT,LCL-2067,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009917""  target=""blank"">CLO_0009917</a>",,,"<a href = ""http://solutions.asterand.com/SUM-149PT-p/cl%20sum-149pt.htm"" target=""blank"">Asterand SUM-149PT</a>",Homo sapiens,breast,,,,,,,,,,,none,,,,not specified,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/10604729""  target=""blank"">PMID 10604729</a>",,2013-07-30,2016-07-12
51083,SUM159PT,SUM-159PT,LCL-2068,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009918""  target=""blank"">CLO_0009918</a>",,,"<a href = ""http://solutions.asterand.com/SUM-159PT-p/cl%20sum-159pt.htm"" target=""blank"">Asterand SUM-159PT</a>",Homo sapiens,breast,,,,,,,,,,,none,,,,not specified,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/10604729""  target=""blank"">PMID 10604729</a>",,2013-07-30,2016-07-12
51084,SUM185PE,SUM-185PE,LCL-2069,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009919""  target=""blank"">CLO_0009919</a>",,,"<a href = ""http://solutions.asterand.com/SUM-185PE-p/cl%20sum-185pe.htm"" target=""blank"">Asterand SUM-185PE</a>",Homo sapiens,breast,,,,,,,,,,,none,,,,not specified,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/10604729""  target=""blank"">PMID 10604729</a>",,2013-07-30,2016-07-12
51085,SUM225CWN,SUM-225CWN,LCL-2070,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009920""  target=""blank"">CLO_0009920</a>",,,"<a href = ""http://solutions.asterand.com/SUM-225CWN-p/cl%20sum-225cwn.htm"" target=""blank"">Asterand SUM-225CWN</a>",Homo sapiens,breast,,,,,,,,,,,none,,,,not specified,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/10604729""  target=""blank"">PMID 10604729</a>",,2013-07-30,2016-07-12
51086,SUM229PE,SUM-229PE,LCL-2065,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009921""  target=""blank"">CLO_0009921</a>",,,"<a href = ""http://solutions.asterand.com/SUM-229PE-p/cl%20sum-229pe.htm"" target=""blank"">Asterand SUM-229PE</a>",Homo sapiens,breast,,,,,,,,,,,none,,,,not specified,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/10604729""  target=""blank"">PMID 10604729</a>",,2013-07-30,2016-07-12
51087,SUM52PE,SUM-52E,LCL-2071,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037189""  target=""blank"">CLO_0037189</a>",,,"<a href = ""http://solutions.asterand.com/SUM-52PE-p/cl%20sum-52pe.htm"" target=""blank"">Asterand SUM-52PE</a>",Homo sapiens,breast,,,,,,,,,,,none,,,,not specified,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/10604729""  target=""blank"">PMID 10604729</a>",,2013-07-30,2016-07-12
51088,184A1,,LCL-2080,"<a href = ""http://purl.obolibrary.org/obo/CLO_0001137""  target=""blank"">CLO_0001137</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-8798"" target=""blank"">ATCC CRL-8798</a>",Homo sapiens,breast,,,,,,,,,,,none,,,,adherent,,,,2013-07-30,2016-07-12
51089,MCF12A,MCF-12A,LCL-2082,"<a href = ""http://purl.obolibrary.org/obo/CLO_0007603""  target=""blank"">CLO_0007603</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-10782"" target=""blank"">ATCC CRL-10782</a>",Homo sapiens,breast,,,,,,,,,,,none,,,,adherent,,,,2013-07-30,2016-07-12
51090,MX1,MX-1,LCL-2072,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009915""  target=""blank"">CLO_0009915</a>",,,"<a href = ""https://dtp.cancer.gov/repositories/default.htm"" target=""blank"">DTP, DCTD Tumor Repository, National Cancer Institute</a>",Homo sapiens,breast,,,,,,,,,,,none,,,,not specified,,,,2013-07-30,2016-07-12
51091,T47DKBLUC,T47D-KBluc,LCL-2064,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037191""  target=""blank"">CLO_0037191</a>",,,"<a href = ""http://www.atcc.org/Products/All/CRL-2865"" target=""blank"">ATCC CRL-2865</a>",Homo sapiens,breast,,,,,,,,,,The parent cell line was transfected with pGL2.TATA.Inr.luc.neo which contains three estrogen responsive elements upstream of a luc reporter gene. The cells were selected for responsiveness to 17-beta-estradiol.,pGL2.TATA.Inr.luc.neo integration,,,,adherent,,,,2013-07-30,2016-07-12
51092,600MPE,,LCL-2073,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009908""  target=""blank"">CLO_0009908</a>",,,H.S. Smith (California Pacific Medical Center),Homo sapiens,breast,,,,,,,,,,,,,,,,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/3470538""  target=""blank"">PMID 3470538</a>",,2013-07-30,2016-07-12
51093,HCC2185,,LCL-2074,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009909""  target=""blank"">CLO_0009909</a>",,,Adi Gazdar (University of Texas-Southwestern Medical Center),Homo sapiens,breast,,,,female,38,white,,"DOID:3008, ductal carcinoma",breast ductal carcinoma,,none,,,,non-adherent,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/9833771""  target=""blank"">PMID 9833771</a>",,2013-07-30,2016-07-12
51094,HCC3153,,LCL-2075,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009910""  target=""blank"">CLO_0009910</a>",,,Adi Gazdar (University of Texas-Southwestern Medical Center),Homo sapiens,breast,,,,,,,,,,,,,,,,,,,2013-07-30,2016-07-12
51095,LY2,LY 2,LCL-2076,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009913""  target=""blank"">CLO_0009913</a>",,,Mark Lippman (National Cancer Institute),Homo sapiens,breast,,,,,,,,,,"The cell line was selected by increasing the concentration of LY 117018, a potent antiestrogen that inhibits cell growth at concentrations as low as 10(-10) M, in the growth medium in a stepwise manner from 10(-8) to 10(-6) M as the cells become resistant.",none,,,,,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/4029083""  target=""blank"">PMID 4029083</a>",,2013-07-30,2016-07-12
51096,ZR75B,,LCL-2077,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009924""  target=""blank"">CLO_0009924</a>",,,Mark Lippman (National Cancer Institute),Homo sapiens,breast,,,,,,,,,,,,,,,,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/7439217""  target=""blank"">PMID 7439217</a>",,2013-07-30,2016-07-12
51097,BCWM.1,,LCL-2094,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009833""  target=""blank"">CLO_0009833</a>",,,Steven Treon (Dana Farber Cancer Center),Homo sapiens,blood,,,,female,,,,"DOID:0050747, lymphoplasmacytic lymphoma",B-cell lymphocytic neoplasm characterized by an uncontrolled increase of B-cells,,none,,,,,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/17761288""  target=""blank"">PMID 17761288</a>",,2014-06-26,2016-07-12
51098,MWCL.1,,,,,,Stephen M. Ansell (Mayo Clinic),Homo sapiens,blood,,,,male,73,,,"DOID:0050747, lymphoplasmacytic lymphoma",B-cell lymphocytic neoplasm characterized by an uncontrolled increase of B-cells,,none,,,,,,"<a href = ""http://www.ncbi.nlm.nih.gov/pubmed/21415268""  target=""blank"">PMID 21415268</a>",,2014-06-26,2016-07-12
51099,NGP,,LCL-2103,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037091""  target=""blank"">CLO_0037091</a>",,,"<a href = ""http://www.creative-bioarray.com/NGP-CSC-C2562-item-1458.htm"" target=""blank"">Creative Bioarray CSC-C2562</a>",Homo sapiens,nervous system,,,,,,,,"DOID:769, neuroblastoma",,,,,,,,,"Thiele CJ. Neuroblastoma: In (Ed.) Masters, J. Human Cell Culture. Lancaster, UK: Kluwer Academic Publishers. 1998, Vol 1, p 21-53.",,2014-06-26,2016-07-12
51100,K2,,LCL-2091,"<a href = ""http://purl.obolibrary.org/obo/CLO_0037127.""  target=""blank"">CLO_0037127</a>",,,Hensin Tsao (Masschusetts General Hospital),Homo sapiens,skin,,,,,,,,"DOID:1909, malignant melanoma",,,,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=1298160""  target=""blank"">COSS1298160</a>",,,,,,2015-01-10,2016-07-12
51101,SKMEL28,SK-MEL-28,LCL-2092,"<a href = ""http://purl.obolibrary.org/obo/CLO_0009043""  target=""blank"">CLO_0009043</a>",,,"<a href = ""http://www.atcc.org/Products/All/HTB-72"" target=""blank"">ATCC HTB-72</a>",Homo sapiens,skin,,,,male,51,,,"DOID:1909, malignant melanoma",,,none,,"<a href = ""http://cancer.sanger.ac.uk/cell_lines/sample/overview?id=905954""  target=""blank"">COSS905954</a>",,adherent,,,,2015-01-10,2016-07-12
51102,HeLa ICRP,,LCL-2096,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003684""  target=""blank"">CLO_0003684</a>",HeLa,HMSL50061-2,Jeremie Roux (Harvard Medical School),Homo sapiens,cervix,,epithelial,,,,,,"DOID:3702, cervical adenocarcinoma",,Modification type: stable retroviral transformation; integrated plasmid: IC-RP (2xIETD). Citation: IC-RP: Addgene Plasmid #24536.,IC-RP (2xIETD) integration,,,,adherent,,,,2015-06-10,2016-07-12
51103,HeLa ICRP FLIP-L-mCherry,,LCL-2099,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003684""  target=""blank"">CLO_0003684</a>",HeLa ICRP,HMSL51102-1,Jeremie Roux (Harvard Medical School),Homo sapiens,cervix,,epithelial,,,,,,"DOID:3702, cervical adenocarcinoma",,Modification type: retroviral transformation with pQCXIP-FLIP-L-mCherry and maintenance as a heterogenous population; integrated plasmids: IC-RP (2xIETD); pQCXIP-FLIP-L-mCherry. Citations: IC-RP: Addgene Plasmid #24536; FLIP-L parental plasmid: Inna Lavrik (Otto von Guericke University).,IC-RP (2xIETD) and pQCXIP-FLIP-L-mCherry integration,,,,adherent,,,,2015-06-10,2016-07-12
51104,HeLa ICRP FLIP-S-mCherry,,LCL-2100,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003684""  target=""blank"">CLO_0003684</a>",HeLa ICRP,HMSL51102-1,Jeremie Roux (Harvard Medical School),Homo sapiens,cervix,,epithelial,,,,,,"DOID:3702, cervical adenocarcinoma",,Modification type: retroviral transformation with pQCXIP-FLIP-S-mCherry and maintenance as a heterogenous population; integrated plasmids: IC-RP (2xIETD); pQCXIP-FLIP-S-mCherry. Citations: IC-RP: Addgene Plasmid #24536; FLIP-S parental plasmid: Inna Lavrik (Otto von Guericke University).,IC-RP (2xIETD) and pQCXIP-FLIP-S-mCherry integration,,,,adherent,,,,2015-06-10,2016-07-12
51105,HeLa ICRP Bcl-2-mCherry,,LCL-2097,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003684""  target=""blank"">CLO_0003684</a>",HeLa ICRP,HMSL51102-1,Jeremie Roux (Harvard Medical School),Homo sapiens,cervix,,epithelial,,,,,,"DOID:3702, cervical adenocarcinoma",,"Modification type: retroviral transformation with pQCXIP-Bcl-2-mCherry and maintenance as a heterogenous population; integrated plasmids: IC-RP (2xIETD); pQCXIP-Bcl-2-mCherry. Citations: IC-RP: Addgene Plasmid #24536; pQCXIP-Bcl-2-mCherry: John Bachman (Peter Sorger group, Harvard Medical School).",IC-RP (2xIETD) and pQCXIP-Bcl-2-mCherry integration,,,,adherent,,,,2015-06-10,2016-07-12
51106,HeLa ICRP Bcl-XL-mCherry,,LCL-2098,"<a href = ""http://purl.obolibrary.org/obo/CLO_0003684""  target=""blank"">CLO_0003684</a>",HeLa ICRP,HMSL51102-1,Jeremie Roux (Harvard Medical School),Homo sapiens,cervix,,epithelial,,,,,,"DOID:3702, cervical adenocarcinoma",,"Modification type: retroviral transformation with pQCXIP-Bcl-XL-mCherry and maintenance as a heterogenous population; integrated plasmids: IC-RP (2xIETD); pQCXIP-Bcl-XL-mCherry. Citations: IC-RP: Addgene Plasmid #24536; pQCXIP-Bcl-XL-mCherry: John Bachman (Peter Sorger group, Harvard Medical School).",IC-RP (2xIETD) and pQCXIP-Bcl-XL-mCherry integration,,,,adherent,,,,2015-06-10,2016-07-12
